mTOR Regulation of N-Myc Downstream Regulated 1 (NDRG1) Phosphorylation in Clear Cell Renal Cell Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• The mechanistic target of rapamycin (mTOR) kinase is crucial in cell growth and survival, existing in two complexes: mTORC1 and mTORC2.
• Clear cell renal cell carcinoma (ccRCC) is a significant malignancy where aberrant signaling pathways contribute to tumor progression.
• Identifying key proteins regulated by mTOR in ccRCC is essential for understanding disease mechanisms and developing targeted therapies.

Purpose of the Study:

• To identify proteins phosphorylated by mTOR that are differentially expressed in ccRCC compared to normal renal tissue.
• To elucidate the specific mTOR complex involved in the phosphorylation of identified proteins.
• To investigate the functional role of this phosphorylation in ccRCC cell viability and apoptosis.

Main Methods:

• Proteomic array analysis to screen for differentially phosphorylated proteins in ccRCC.
• Western blotting and quantitative real-time PCR to validate protein and mRNA expression.
• siRNA-mediated knockdown of RICTOR (a subunit of mTORC2) to assess its role in NDRG1 phosphorylation.
• Pharmacological inhibition of mTORC1 and mTORC2 using rapamycin and Torin 2, respectively.
• Cell viability and apoptosis assays to evaluate the functional consequences of mTOR inhibition.

Main Results:

• N-Myc Downstream Regulated 1 (NDRG1) phosphorylation at Thr346 was significantly increased (3.3-fold) in ccRCC, along with total NDRG1 levels.
• Knockdown of RICTOR reduced both total and phospho-NDRG1 (Thr346), indicating mTORC2 involvement.
• The dual mTORC1/2 inhibitor Torin 2 abolished phospho-NDRG1 (Thr346), while the selective mTORC1 inhibitor rapamycin had no effect.
• Inhibition of mTORC2 led to decreased cell viability and increased apoptosis in ccRCC cells, whereas rapamycin did not affect viability.

Conclusions:

• mTORC2, specifically through its subunit RICTOR, mediates the phosphorylation of NDRG1 at Thr346 in ccRCC.
• The phosphorylation of NDRG1 by mTORC2 is critical for promoting the viability and survival of ccRCC cells.
• Targeting mTORC2 signaling represents a potential therapeutic strategy for ccRCC.